Privacy Policy

THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.

I. Background
Prometheus provides clinical laboratory testing services and markets pharmaceutical products. In providing testing services, Prometheus receives, creates and discloses personal health information. In fulfilling regulatory requirements related to the pharmaceutical products, Prometheus may receive and disclose personal health information. This information is private and confidential. There are policies and procedures in place to protect the information against unlawful use and disclosure. This notice describes information we collect, how we use that information, and when and to whom we may disclose it.

II. Protected Health Information and Our Obligations
Protected health information or "PHI" (also called "personal health information"), is current, past or future information created or received by Prometheus from physicians, patients, health plans or other sources. It is personal or medical information that relates to the physical condition of a patient, the provision of health care to that person, or payment for the provision of health care to that person. The term PHI does not generally include publicly available information, or information available or reported in a summarized or grouped manner.

Certain laws require Prometheus to maintain the privacy of PHI and to make available this notice of our legal duties and privacy practices with respect to PHI. When we use or disclose PHI, we are required to abide by the terms of this notice (or other notice in effect at the time of the use or disclosure).

III. Information Collected and Created by Prometheus
Prometheus collects that information that is minimally necessary to provide testing services and to obtain payment for these services. This may include your name, address, telephone number, social security number, date of birth, medical history, diagnosis, treatment, provider identification and treatment information, financial responsibility and payment information.

Prometheus creates, through its testing services, information to be used by a physician in the diagnosis of disease or condition or in the treatment of a disease or condition.

Prometheus also receives information that is minimally necessary to perform reporting to the Food and Drug Administration when an unexpected or adverse event occurs in the use of our pharmaceutical products.

IV. Protection of PHI
Access to PHI is restricted to only those employees of Prometheus who need it in order to provide services to clients and patients. We maintain physical, technical and procedural safeguards to protect PHI against unauthorized use and disclosure. We have a Privacy Officer who is responsible for developing, educating Prometheus personnel about, and overseeing the implementation and enforcement of policies and procedures designed to safeguard PHI against inappropriate use and disclosure consistent with the applicable law.

V. Standard Uses and Disclosures of PHI
In the course of providing laboratory services, Prometheus uses PHI internally and discloses it to health care providers (doctors requesting services, laboratory personnel involved in ordering services and other caregivers), insurers, third party administrators, plan sponsors and other payors (employers, health care provider organizations and others who may be responsible for paying for or administering your health benefits); vendors, consultants, government authorities; and their respective agents. They are required by law to keep PHI confidential. Some examples of what we do with the information we collect and the reasons it might be disclosed to third parties are described below.

We may use or disclose PHI with or without your consent to provide health care services. Examples of these uses and disclosures include:

Other Activities Permitted or Required by Law
We may use or disclose PHI for other important activities permitted or required by law, with or without your authorization. These include:

Our use and disclosure of PHI must comply not only with federal privacy regulations but also with applicable California law.

VI. Requesting Other Disclosures
It is possible to request that we disclose PHI to people in ways not described above. To authorize us to disclose your personal health information to a person or organization or for reasons other than those described in the section above, see the contact information at the bottom of this page. If you make a special authorization and later change your mind about this, you may send a letter to us to let us know that you would like to revoke the special authorization. In any communication with us, please provide your name, address, patient identification number or Social Security number, and a telephone number where we can reach you in case we need to contact you about your request.

VII. Your Rights with Respect to PHI

VIII. Distribution and Updates of This Notice
This notice is published on the Prometheus web site at www.prometheuslabs.com/PrivacyNotice and is made available in printed form upon request.

IX. Effective Date and Duration of This Notice
This notice describes the privacy policy of Prometheus that will become effective on or after April 14, 2003, the date that federal law specifies for these protections. Prior to the effective date, Prometheus will continue to protect your PHI as required by other applicable laws, regulations, and policies.

We may change the terms of this notice at any time. If we change this notice, we may make the new notice terms effective for all PHI that we maintain, including any information created or received prior to issuing the new notice. If we change this notice, we will post the new notice on our Internet site at www.prometheuslabs.com.

X. Communication with Prometheus
As a convenience, Prometheus may make available email addresses by which you can communicate with us regarding billing issues. Please be advised that email is not a secure means of communication, therefore Prometheus cannot guarantee the security of any information that you send to us prior to our receipt of it. This fact may also restrict our use of email in communicating any response to you - we will make every attempt to use alternate means of communicating anything that may be considered sensitive information.

XI. Copy of Notice, Questions or Complaints
If you would like a paper copy of this notice, have questions about it, or believe its terms or any Prometheus privacy or confidentiality policy has been violated with respect to information about you, please let us know immediately by contacting us toll-free at 1-888-423-5227 and request the Compliance/Privacy Office. Please include your name, address, and a telephone number where we can contact you, and a brief description of the complaint. If you prefer, you may lodge an anonymous complaint.

Compliance/Privacy Office
Prometheus Laboratories Inc.
9410 Carroll Park Drive
San Diego, CA 92121

Or call our Ethics Hotline at 1-800-794-9193

You also may contact the Secretary of the Department of Health and Human Services at:
The U.S. Department of Health and Human Services
200 Independence Avenue, S.W.
Washington, D.C. 20201
(202) 619-0257
Toll Free: 1-877-696-6775

Please provide as much information as possible so that the complaint can be properly investigated. Prometheus will not retaliate against a person who files a complaint with us or with the Secretary of the Department of Health and Human Services.

The PROMETHEUS IBS Diagnostic is not currently available to residents of New York State.